Tri Locum Partners LP Argenx Se Transaction History

Tri Locum Partners LP

$374 Million
Q3 2024

A detailed history of Tri Locum Partners LP transactions in Argenx Se stock. As of the latest transaction made, Tri Locum Partners LP holds 62,474 shares of ARGX stock, worth $35.2 Million. This represents 9.05% of its overall portfolio holdings.

Number of Shares

62,474

Previous 74,558 16.21%

Holding current value

$35.2 Million

Previous $32.1 Million 5.68%

% of portfolio

9.05%

Previous 8.28%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $5.25 Million - $6.67 Million	-12,084 Reduced 16.21%	62,474 $33.9 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $16.6 Million - $21 Million	46,577 Added 166.46%	74,558 $32.1 Million
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $1.36 Million - $1.57 Million	3,799 Added 15.71%	27,981 $11 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $3.33 Million - $4.98 Million	9,836 Added 68.56%	24,182 $9.2 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $5.3 Million - $7.87 Million	14,346 New	14,346 $7.05 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $21.5 Million - $25.3 Million	-62,853 Reduced 97.98%	1,299 $492,000
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $6.38 Million - $7.35 Million	-18,583 Reduced 22.46%	64,152 $22.6 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $12.6 Million - $17.8 Million	46,855 Added 130.59%	82,735 $31.3 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $3.17 Million - $4.38 Million	-12,467 Reduced 25.79%	35,880 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $13.2 Million - $17.1 Million	48,347 New	48,347 $16.9 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $1.89 Million - $2.25 Million	-6,408 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $1.65 Million - $2.05 Million	6,408 New	6,408 $1.93 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Account

Tri Locum Partners LP Argenx Se Transaction History